发明名称 PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide clavulanic acid particles with especially improved gastrointestinal absorption after oral administration, and to provide a method for producing the same and a pharmaceutical composition. SOLUTION: Provided is the clavulanic acid or a salt thereof in which the median of the particles is from 8μm to 35μm. Provided is the process for the production of clavulanic acid comprising a step (a) of isolating clavulanic acid from an organic solvent, and a step (b) of treating the particles obtained in step (a) in a combined drier/mixer until the median of the particles becomes between 8μm and 35μm. Provided is the pharmaceutical composition including the clavulanic acid or it salt particles, in the form of tablets, film-coated tablets, chewing tablets, powders for oral suspensions or dispersible tablets. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009197020(A) 申请公布日期 2009.09.03
申请号 JP20090112262 申请日期 2009.05.01
申请人 SANDOZ AG 发明人 HORKOVICS-KOVATS STEFAN;RANEBURGER JOHANNES;SCHWARZ FRANZ XAVER
分类号 C07D503/00;C12P17/14;A61K9/10;A61K9/14;A61K9/20;A61K9/28;A61K31/424;A61K31/43;A61P31/04;A61P43/00;C07D503/02 主分类号 C07D503/00
代理机构 代理人
主权项
地址